{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:32:36Z","timestamp":1773340356671,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.trsl.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T14:56:44Z","timestamp":1203001004000},"page":"208-216","source":"Crossref","is-referenced-by-count":39,"title":["Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats"],"prefix":"10.1016","volume":"151","author":[{"given":"David J.","family":"Leehey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periannan","family":"Sethupathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2008.01.003_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2008.01.003_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1523-1755.2000.00880.x","article-title":"Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy","volume":"57","author":"Andersen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1507\/endocrj.K06-025","article-title":"Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes","volume":"53","author":"Igarashi","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/j.trsl.2008.01.003_bib4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1523-1755.2001.0590041432.x","article-title":"Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus","volume":"59","author":"Lansang","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2008.01.003_bib6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI112521","article-title":"Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension","volume":"77","author":"Zatz","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2008.01.003_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1681\/ASN.V4140","article-title":"Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes","volume":"4","author":"Remuzzi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2008.01.003_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3317\/jraas.2004.032","article-title":"Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat","volume":"5","author":"Erman","year":"2004","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.trsl.2008.01.003_bib9","doi-asserted-by":"crossref","first-page":"F477","DOI":"10.1152\/ajprenal.1993.265.4.F477","article-title":"Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations","volume":"265","author":"Anderson","year":"1993","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.trsl.2008.01.003_bib10","doi-asserted-by":"crossref","first-page":"F1183","DOI":"10.1152\/ajprenal.00159.2003","article-title":"A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli","volume":"288","author":"Singh","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2008.01.003_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/labinvest.3780392","article-title":"Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats","volume":"82","author":"Hoshi","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2008.01.003_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1291\/hypres.25.271","article-title":"Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes","volume":"25","author":"Mizuno","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.trsl.2008.01.003_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1291\/hypres.25.287","article-title":"Role of intrarenal angiotensin-converting enzyme in nephropathy of type II diabetic rats","volume":"25","author":"Taniguchi","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.trsl.2008.01.003_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.ASN.0000060804.40201.6E","article-title":"Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose","volume":"14","author":"Singh","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2008.01.003_bib15","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2008.01.003_bib16","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2008.01.003_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1139\/y02-021","article-title":"ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors","volume":"80","author":"Turner","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.trsl.2008.01.003_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2008.01.003_bib19","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1681\/ASN.2006050423","article-title":"Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implication for albuminuria in diabetes","volume":"17","author":"Ye","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2008.01.003_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"Soler","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2008.01.003_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury","volume":"171","author":"Wong","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2008.01.003_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1681\/ASN.V11180","article-title":"Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells","volume":"11","author":"Kim","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2008.01.003_bib23","doi-asserted-by":"crossref","first-page":"39616","DOI":"10.1074\/jbc.M502412200","article-title":"Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney","volume":"280","author":"Gorin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2008.01.003_bib24","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-b expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2008.01.003_bib25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/diabetes.48.10.2066","article-title":"Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation","volume":"48","author":"Singh","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2008.01.003_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7150\/ijbs.3.40","article-title":"Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats","volume":"3","author":"Suzaki","year":"2007","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.trsl.2008.01.003_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2741\/1853","article-title":"Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes","volume":"11","author":"Sharma","year":"2006","journal-title":"Front Biosci"},{"issue":"suppl 1","key":"10.1016\/j.trsl.2008.01.003_bib28","doi-asserted-by":"crossref","first-page":"I110","DOI":"10.1161\/01.HYP.19.1_Suppl.I110","article-title":"The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury","volume":"19","author":"Kasiske","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2008.01.003_bib29","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00017.2006","article-title":"Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenic relevance","volume":"292","author":"Bidani","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2008.01.003_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00592-007-0007-6","article-title":"Effect of TNF-\u03b1 inhibition on urinary albumin excretion in experimental diabetic rats","volume":"44","author":"Moriwaki","year":"2007","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.trsl.2008.01.003_bib31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1046\/j.1523-1755.2003.00237.x","article-title":"Urinary and renal interstitial concentrations of TNF-\u03b1 increase prior to the rise in albuminuria in diabetic rats","volume":"64","author":"Kalantarinia","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2008.01.003_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/db06-1018","article-title":"Evidence for a role of transforming growth factor (TGF)-\u03b21 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-\u03b2 type II receptors","volume":"56","author":"Russo","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2008.01.003_bib33","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1210\/en.140.11.5285","article-title":"Insulin inhibits angiotensinogen gene expression via the mitogen-activated protein kinase pathway in rat kidney proximal tubular cells","volume":"140","author":"Zhang","year":"1999","journal-title":"Endocrinology"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524408000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524408000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T07:56:15Z","timestamp":1630742175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524408000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1931524408000200"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2008.01.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}